Press release from Companies: Curasight A/S resolves on directed issues and a loan facility

Press release from Companies: Curasight A/S resolves on directed issues and a loan facility

Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer

Press release from Companies: Curasight Announces Enrollment of First Patient in Phase 2 trial with uTRACE[®] in Prostate Cancer

Reports: Interim report Q1 2024

Press release from Companies: Curasight announces approval of clinical trial application (CTA) for phase 2 trial with uTRACE[®] in prostate cancer patients

Press release from Companies: Curasight announces change in the Board of Directors

Press release from Companies: Curasight announces change in the Board of Directors

Press release from Companies: Resolutions of the Annual General Meeting 2024 of Curasight A/S

Press release from Companies: Curasight not to proceed with rights issue; evaluating alternative financing opportunities

Press release from Companies: Notice of Annual General Meeting 2024

Press release from Companies: The subscription period in Curasight’s rights issue begins today